VERU Veru Inc.

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.

$8.27  -0.32 (-3.73%)
As of 10/18/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  79,853,748
Average volume:  445,125
Market cap:   $697,921,758
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92536C103
ISIN:        US92536C1036
Valuation   (See tab for details)
PE ratio:   -4,774.87
PB ratio:   4.43
PS ratio:   12.17
Return on equity:   -11.20%
Net income %:   -30.25%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy